Vanguard Capital Opportunity Adm VHCAX

Medalist Rating as of | See Vanguard Investment Hub
  • NAV / 1-Day Return 204.38  /  +0.28 %
  • Total Assets 23.0 Bil
  • Adj. Expense Ratio
    0.360%
  • Expense Ratio 0.360%
  • Distribution Fee Level Low
  • Share Class Type Institutional
  • Category Large Growth
  • Investment Style Large Growth
  • Min. Initial Investment 50,000
  • Status Limited
  • TTM Yield 0.66%
  • Turnover 6%

USD | NAV as of Oct 02, 2024 | 1-Day Return as of Oct 02, 2024, 10:28 PM GMT+0

Morningstar’s Analysis VHCAX

Will VHCAX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

Still strong after a middling half-decade.

Strategist Robby Greengold

Robby Greengold

Strategist

Summary

We have qualitatively reviewed this strategy and reaffirmed its Process and People ratings. Vanguard Capital Opportunity stands out for its seasoned management and high-conviction multimanager system. The remainder of this analysis is from July 7, 2023.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings VHCAX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 33.3
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Eli Lilly and Co

12.02 2.8 Bil
Healthcare

Amgen Inc

2.87 664.2 Mil
Healthcare

Micron Technology Inc

2.85 660.1 Mil
Technology

Microsoft Corp

2.67 618.3 Mil
Technology

KLA Corp

2.56 592.9 Mil
Technology

Biogen Inc

2.34 543.6 Mil
Healthcare

FedEx Corp

2.13 494.5 Mil
Industrials

Mktliq 12/31/2049

2.12 491.1 Mil
Cash and Equivalents

NVIDIA Corp

1.99 461.4 Mil
Technology

Biomarin Pharmaceutical Inc

1.95 451.7 Mil
Healthcare

Sponsor Center